Invest in ME Conference 12: First Class in Every Way
OverTheHills wraps up our series of articles on this year's 12th Invest in ME International Conference (IIMEC12) in London with some reflections on her experience as a patient attending the conference for the first time.
Discuss the article on the Forums.

Lipopolysaccharide Antagonist Molecule AM-12

Discussion in 'The Gut: De Meirleir & Maes; H2S; Leaky Gut' started by JPV, Aug 19, 2015.

  1. JPV

    JPV ɹǝqɯǝɯ ɹoıuǝs

    Messages:
    858
    Likes:
    1,079
    Has anybody heard of this before?
     
    rosie26 likes this.
  2. msf

    msf Senior Member

    Messages:
    3,185
    Likes:
    4,435
    Looks promising, at least for those with leaky gut. I don´t know if you would want to do this with a pathogenic bacteria though, I guess it would depend on how virulent it was.
     
  3. alex3619

    alex3619 Senior Member

    Messages:
    12,394
    Likes:
    34,725
    Logan, Queensland, Australia
    LPS is a super antigen. It can drive someone with a LPS based bacterial infection into septic shock. Blocking LPS will not stop the immune system from fighting a bacterial infection. It will just slow down the severity and speed of the immune response. In anyone with a severe immune response this would be a good thing.

    I would like to see human clinical trials if the research keeps showing results.
     
    rosie26 likes this.
  4. msf

    msf Senior Member

    Messages:
    3,185
    Likes:
    4,435
    I was referring to its potential use in ME, rather than in sepsis.

    KDM has talked about the potential efficacy of such a approach in Lyme.
     

See more popular forum discussions.

Share This Page